Serametrix has built strategic partnerships with organizations that add value to our research through their specialized disease expertise, knowledge in specific therapeutic and diagnostic areas and access to well characterized samples and clinical data. We have established partnerships across three sectors: Pharmaceutical, Academic and Diagnostic.
Pharmaceutical partnerships: Serametrix currently partners with 3 of the top 5 pharmaceutical partners to make effective use of the Seromic™ technology in drug discovery and development. We work together to provide a greater understanding of the effects of new drugs and to identify and monitor responders to new drugs. This enables accelerated clinical development and a clearer route to regulatory approval.
Academic and clinical partnerships: By tapping into the broader knowledge of world experts, we are able to further our understanding of the mechanisms of pathology underlying disease. Whether conducting basic research into disease etiology, or practical testing of patient serum samples, this collaborative approach delivers the benefits of combined expertise.
Diagnostic partnerships: Serametrix is committed to breaching the "biomarker bottleneck" and we actively seek partnership with members of the diagnostic industries. The aim of these alliances is to push forward biomarker panels from discovery, beyond validation to every-day use in clinical laboratories around the world so that bench-top discoveries can be effectively translated into bedside improvements in patient care.
Serametrix leverages a strong research team with strategic partnerships to deliver the highest quality research related to "Biomarker Discovery, Biomarker Validation and Personalized Medicine."
To learn more, email email@example.com.